Axon Neuroscience R&D Services SE is a clinical-stage biotech company developing disease-modifying immunotherapeutics for Alzheimer's disease and Frontotemporal lobar degeneration. Ground-breaking discoveries in Alzheimer’s disease research made by AXON Neuroscience R&D Services SE enabled the company to create a therapeutic platform of global importance.
The target products of strategic importance in this platform are revolutionary therapeutic candidate vaccines for treatment of Alzheimer's disease and Frontotemporal lobar degeneration.
AXON Neuroscience R&D Services SE has developed unique animal models that reproduce Alzheimer’s disease and allow for a swift and effective pre-clinical validation of efficacy of new therapeutics and pre-clinical evaluation of diagnostic tools.